Home Medical Devices Infusion Pump Software Market Size, Share and Forecast to 2031

Infusion Pump Software Market

Infusion Pump Software Market Size, Share & Trends Analysis Report By Type (Interoperability Software, Dose Error Reduction Software (DERS), Clinical Workflow Software), By Indication (General Infusion, Insulin Infusion, Pain and Anesthesia Management, Chemotherapy, Others), By End-User (Hospitals, Home Healthcare Settings, Ambulatory Centers Settings, Academic and Research Institutes, Others) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2023-2031

Report Code: SRMD54798DR
Study Period 2019-2031 CAGR 7.5%
Historical Period 2019-2021 Forecast Period 2023-2031
Base Year 2022 Base Year Market Size USD 745 Billion
Forecast Year 2031 Forecast Year Market Size USD 1428 Million
Largest Market North America Fastest Growing Market Europe
The sample report only takes 30 secs to download, no need to wait longer.

Market Overview

The global Infusion pump software market size was valued at USD 745 billion in 2022 and is projected to reach USD 1,428 million by 2031, registering a CAGR of 7.5% during the forecast period (2023-2031).

Computer programs and applications particularly developed to manage and monitor infusion pumps in healthcare environments are called Infusion Pump Software. Infusion pumps provide fluids such as medications, blood, and nutrients to a patient's body in a precise and regulated manner. The software used in infusion pumps provides functions such as dose calculations, pharmaceutical libraries, alarm systems, communication options, and data management. Ensuring precise and safe medicine distribution is crucial, improving patient safety, and increasing healthcare professional workflow efficiency is crucial.

The global infusion pump software market growth is influenced by Factors such as technology improvements, rising chronic illness incidence, regulatory requirements, integration with electronic health record (EHR) systems, and the desire for improved patient safety and workflow optimization in healthcare institutions all have an impact.


  • Dose error reduction software (DERS) owns the largest market share based on type. 
  • General infusion holds the major share in the market based on Indication.
  • Based on end-user, hospitals led the market.
  • North America is the most dominating region.

Market Dynamics

Global Infusion Pump Software Market Drivers

Increasing Prevalence of Chronic Diseases

Diabetes is a common chronic condition affecting millions of individuals worldwide. It needs careful administration and monitoring of blood glucose levels by insulin infusion or other drugs. Healthcare practitioners may use infusion pump software to design exact insulin doses, alter infusion rates based on patient needs, and monitor glucose levels to achieve optimal glycemic control. According to the International Diabetes Federation (IDF), roughly 463 million persons aged 20 to 79 had diabetes worldwide in 2021. This figure is predicted to climb to 700 million by 2045. Diabetes' rising prevalence needs effective and efficient drug administration, fueling demand for infusion pump software to correctly regulate insulin supply and reduce problems associated with poorly managed diabetes. Aside from diabetes, infusion pump software is used to treat various other chronic conditions. For example, cancer patients may require long-term chemotherapy or immunotherapy therapies that necessitate continuous pharmaceutical infusion. Healthcare practitioners may use infusion pump software to accurately regulate medicine doses, manage infusion rates, and evaluate patient reactions to therapy.

Global Infusion Pump Software Market Restraints

Stringent Regulations

While stringent FDA rules are essential for patient safety and quality control, they can result in lengthier and more expensive approval procedures for infusion pump software. Manufacturers must undergo significant testing, clinical studies, and paperwork to ensure their goods meet regulatory criteria before marketing. Delays in the clearance process may stymie product releases and limit market entrance, impacting both new entrants' and current firms' growth prospects. The Food and Drug Administration (FDA) oversees medical equipment in the United States, including infusion pumps and software. To assure the safety and efficacy of these devices, the FDA establishes stringent criteria for their design, production, testing, and labeling.

Global Infusion pump software Market Opportunities

Increasing Research and Development Activities

Increasing R&D activities centered on AI integration and other technical breakthroughs provide chances for businesses to build cutting-edge infusion pump software solutions. Manufacturers may produce software with greater safety features, improved connectivity, and quicker processes for healthcare professionals by investing in R&D. These advancements may entice more healthcare institutions to use cutting-edge technology, boosting market development. Furthermore, R&D efforts might result in customized infusion pump software that caters to particular patient needs and treatment regimens. Healthcare practitioners can maximize therapeutic outcomes and decrease the risk of adverse events by personalizing medicine delivery to each patient's needs.

Regional Analysis

North America Dominates the Global Market

The global infusion pump software market is analyzed in North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa.

North America highly contributes to the infusion pump software market share and is expected to expand at a CAGR of 7.2% during the forecast period. The present expansion of the North American infusion pump software market may be ascribed mostly to the home healthcare segment, as well as patients and clinicians, who consistently embrace new technologically sophisticated solutions for the routine treatment of chronic medical conditions. The infusion pump software market in the region has been experiencing significant growth, driven by increased patient awareness, the growing prevalence of chronic diseases, the increasing number of surgeries performed in the region, and the need to control escalating healthcare costs. Each year, roughly 27 million surgical operations are conducted in the United States, according to the Journal of Infectious Disease Adviser. Flowonix Medical, Inc. got US Food and Drug Administration (FDA) market clearance for its Maestro Infusion Pump Software Upgrade for Clinician Programmers in February 2019.

Europe has the second-largest market share and is anticipated to increase at a CAGR of 7.3%. Growth in the frequency of chronic illnesses in this region and major healthcare spending by the European Commission is expected to fuel demand for these pumps in Europe. Furthermore, diabetes is becoming increasingly widespread in people of all ages throughout Europe. Diabetes affected around 35 million individuals in the EU in 2019, up from 17 million in 2000. In 2019, an extra 25 million diabetes persons in Europe were undiagnosed. Between 2000 and 2019, the number of males diagnosed with diabetes more than quadrupled, rising from around 7.3 million in 2000 to 16.7 million in 2019. As a result, the necessity to provide cost-effective and improved healthcare solutions and services to the region's growing diabetic population has increased the demand for insulin delivery systems.

Asia Pacific was predicted to be the fastest-growing region in the Market. Several factors contribute to the rapid expansion of the Asia Pacific Infusion Pump Software Market. Many Asian Pacific nations, including China, India, and Japan, are investing in healthcare infrastructure and increasing healthcare spending. This encourages innovative healthcare technology, such as infusion pump software. Chronic illnesses are becoming more prevalent in the region. This increases the demand for infusion treatment and, as a result, infusion pump software. Several Asian Pacific governments are concentrating on increasing healthcare facilities, boosting access to healthcare services, and improving patient care. This opens up possibilities for the use of infusion pump software. Significant improvements in healthcare technology and growing acceptance of digital solutions in healthcare have occurred in the region. One example is adopting infusion pump software to improve medicine administration accuracy and patient safety. This promotes the use of such technology in healthcare institutions around the area.

Report Scope

Report Metric Details
By Type
  1. Interoperability Software
  2. Dose Error Reduction Software (DERS)
  3. Clinical Workflow Software
By Indication
  1. General Infusion
  2. Insulin Infusion
  3. Pain and Anesthesia Management
  4. Chemotherapy
  5. Others
By End-User
  1. Hospitals
  2. Home Healthcare Settings
  3. Ambulatory Centers Settings
  4. Academic and Research Institutes
  5. Others
Company Profiles Ypsomed Holding AG Smiths Medical (part of Smiths Group plc) KGaA ICU Medical Inc. Medtronic plc B. Braun Melsungen AG Baxter International Inc.
Geographies Covered
North America U.S. Canada
Europe U.K. Germany France Spain Italy Russia Nordic Benelux Rest of Europe
APAC China Korea Japan India Australia Taiwan South East Asia Rest of Asia-Pacific
Middle East and Africa UAE Turkey Saudi Arabia South Africa Egypt Nigeria Rest of MEA
LATAM Brazil Mexico Argentina Chile Colombia Rest of LATAM
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends
Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Segmental Analysis

The global infusion pump software market is segmented based on type, Indication, end-user, and region.

For better understanding, type is further segmented into Dose error reduction software (DERS), clinical workflow software, and others.

Dose error reduction software (DERS) owns the largest market share.

Dose error reduction software (DERS)

DERS is an important component of infusion pump software that strives to improve patient safety by reducing drug mistakes. This software uses advanced algorithms and safety checks to prevent dosage errors and notify healthcare personnel of potential problems. DERS may identify wrong doses, rate inconsistencies, and drug incompatibility alarms, assuring precise medicine administration and lowering the risk of adverse drug events.

Clinical Workflow Software

Infusion pump clinical workflow software improves and optimizes the drug delivery procedure. Medication order management, drug library customization, and data interaction with electronic health records (EHR) systems are among the capabilities available. This program assists healthcare practitioners in managing infusion treatment more efficiently, reducing administrative stress, and improving overall medication administration workflow.

The segment can be further bifurcated by Indication into general infusion, insulin infusion, Pain and Anesthesia management, chemotherapy, and others.

General infusion holds the major share of the Market.

General Infusion

Providing a wide range of fluids, drugs, and nutrients to patients in various healthcare settings is called general infusion. This area includes the administration of fluids such as saline, dextrose, and electrolyte solutions, as well as drugs for disorders not addressed by the other indication segments. General infusion pump software offers variable dosage choices and safety measures to meet various medical demands.

Insulin Infusion

Insulin infusion is a specific application that involves the continuous administration of insulin to diabetic patients. Insulin management infusion pump software enables accurate programming of insulin dosages, variable basal rates, and bolus doses to ensure optimal glycemic control. It may also be linked to continuous glucose monitoring devices to provide real-time data feedback.

Hospitals, home healthcare, academic research institutes, ambulatory surgical centers, and others are the end-user segments in the Market.

Hospitals led the Market and are expected to grow significantly during the forecast period.


Hospitals frequently have various infusion needs, including departments and specializations where infusion treatment is delivered. Infusion pump software is critical in hospitals because it allows for proper medicine delivery, dose calculations, monitoring, and reporting. Because of the applicability, the growing number of healthcare institutions, and the accompanying data, effective control, and privacy are required. Furthermore, the Market is projected to be driven by government measures to promote the healthcare industry and simplify the complexity of a vast quantity of data in hospitals. Furthermore, the segment is likely to be driven by rising demand for workflow and the continuous trend toward connected hospitals throughout the forecast period. A strong need is pushing the segment's expansion for collaborative and integrated care delivery, unified key clinical communications, and call scheduling process efficiency.

Home Healthcare

In-home healthcare infusion pump software facilitates the safe and efficient administration of medications and fluids by healthcare professionals or patients. The increasing preference for care at home, particularly among patients requiring long-term infusion therapy, drives the demand for infusion pump software in home healthcare. Outpatient facilities or ambulatory care centers provide healthcare services that do not necessitate an overnight hospital stay. This category comprises clinics, surgical centers, and specialized treatment centers.

Market Size By Type

Recent Developments

  • July 2023- Ypsomed joined S3 Connected Health to broaden its digital health offerings.
  • June 2023- Medtronic released new statistics on the MiniMedTM 780G system, including set meal dosage and real-world Time in Range across a wide range of users.
  • June 2023- Baxter Introduced the Progressa+ Next Generation ICU Bed to Address Complex Critical Care Needs.

Top Key Players

Ypsomed Holding AG Smiths Medical (part of Smiths Group plc) KGaA ICU Medical Inc. Medtronic plc B. Braun Melsungen AG Baxter International Inc. Others

Frequently Asked Questions (FAQs)

How big is the Infusion pump software market?
The global Infusion pump software market size was valued at USD 745 billion in 2022 and is projected to reach USD 1,428 million by 2031, registering a CAGR of 7.5% during the forecast period (2023-2031).
Europe has the highest growth in the global market.
Key verticals adopting the market include: Ypsomed Holding AG, Smiths Medical (part of Smiths Group plc), KGaA, ICU Medical, Inc., Medtronic plc, B. Braun Melsungen AG, and Baxter International Inc.
Increasing prevalence of chronic diseases are the key drivers for the growth of the global market.
Increasing research and development activities is one of the upcoming key trends in the global market.

We are featured on :

This website uses cookies to ensure you get the best experience on our website. Privacy Policy